GlassScriptPhysician profile
Rahman G Barry
NPI 1275967838
$5,365.74
in general payments reported to CMS, 2019-2025
9 companies · $4,384 in 2025
The $4,384 reported for 2025 was more than what 91% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $303 · 2023: $259 · 2024: $314 · 2025: $4,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,284 · Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,283.55 |
| Food and Beverage | $673.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $4,431.20 | 2022-2025 | Durasorb Monofilament Mesh, Integra, Primatrix |
| Abbvie INC. | $310.66 | 2023-2024 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Medical Device Business Services, INC. | $199.99 | 2022 | |
| Mentor Worldwide LLC | $151.51 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $57.62 | 2025 | Dysport |
| Smith+Nephew, INC. | $45.95 | 2023-2024 | Collagenase Santyl, Versajet, Oasis |
| Kci USA, INC. | $23.59 | 2023 | Prevena Restor Bellaform, V.A.C. Veraflo, Prevena |
| Aerin Medical INC. | $19.75 | 2025 | |
| Baxter Healthcare | $19.68 | 2023 | Artiss |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahman Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.